DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Capital Goods
Author Program NEWCreate Narrative
TRNS logo

Transcat, Inc. Stock Price

NasdaqGM:TRNS Community·US$758.1m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

TRNS Share Price Performance

US$83.64
11.03 (15.19%)
​
US$104.25
Fair Value
US$83.64
11.03 (15.19%)
19.8% undervalued intrinsic discount
US$104.25
Fair Value
Price US$83.64
AnalystConsensusTarget US$104.25
AnalystLowTarget US$95.00
AnalystHighTarget US$105.00
Wed, 10 Sep 25
Fair ValueUS$104.25
Share Pricen/a

TRNS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$104.25 19.8% undervalued intrinsic discount

Automation And Onshoring Will Expand Life Sciences Markets Despite Headwinds

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$95 12.0% undervalued intrinsic discount

Automation And OEM Disruption Will Erode Recurring Revenues

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$105 20.3% undervalued intrinsic discount

M&A And IoT Trends Will Drive Calibration Industry Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TRNS logo
Transcat
12.0% undervalued intrinsic discount

Automation And OEM Disruption Will Erode Recurring Revenues

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 17 Jun
Read Narrative
TRNS logo
Transcat
20.3% undervalued intrinsic discount

M&A And IoT Trends Will Drive Calibration Industry Expansion

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 2 Jun
Read Narrative
TRNS logo
Transcat
19.8% undervalued intrinsic discount

Automation And Onshoring Will Expand Life Sciences Markets Despite Headwinds

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 6 Sep 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
TRNS logo

TRNS: Acquisition-Led Expansion And Profitability Shift Will Shape Future Share Price

Fair Value: US$95 12.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
TRNS logo

TRNS: M&A Pipeline And New Leadership Will Support Higher Future P/E

Fair Value: US$105 20.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
TRNS logo

Automation And Onshoring Will Expand Life Sciences Markets Despite Headwinds

Fair Value: US$104.25 19.8% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Moderate growth potential with mediocre balance sheet.

3 Risks
2 Rewards
View Full Analysis

Transcat, Inc. Key Details

US$348.4m

Revenue

US$235.2m

Cost of Revenue

US$113.2m

Gross Profit

US$109.8m

Other Expenses

US$3.4m

Earnings

Last Reported Earnings
Jun 27, 2026
Next Reporting Earnings
n/a
0.37
32.50%
0.99%
36.4%
View Full Analysis

About TRNS

Founded
1964
Employees
1413
CEO
Jaime Irick
WebsiteView website
www.transcat.com

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers’ assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers’ test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. It also provides calibration, repair, preventive maintenance, electrical safety inspection, and documentation and regulatory compliance services to hospital networks and healthcare facilities in the southeastern United States. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

Recent TRNS News & Updates

Seeking Alpha • 14h

Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point

Summary Transcat is rated BUY, leveraging a mission-critical, high-retention calibration services business with strong operating leverage and recurring revenue. TRNS delivered robust Q1 FY27 results: revenue rose 22% YoY, service segment operating income surged 35% YoY, and organic service growth was 13% YoY. The stock trades at a 50% discount to its recent EV/EBITDA peak, despite forward EBITDA growth 70% above the industrial sector median. Key risks include tougher YoY comps in 2H and potential M&A integration costs, but TRNS maintains strong interest coverage and near-record free cash flow. Read the full article on Seeking Alpha

Recent updates

No updates

Transcat, Inc. Competitors

EROC logo

ERock

Symbol: NYSE:EROC
Market cap: US$3.0b
DNOW logo

DNOW

Symbol: NYSE:DNOW
Market cap: US$2.9b
ATRO logo

Astronics

Symbol: NasdaqGS:ATRO
Market cap: US$2.9b
PLUG logo

Plug Power

Symbol: NasdaqCM:PLUG
Market cap: US$2.9b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide